Pay in 4 interest-free payments of $6.14 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Supplemental Dataset 1: Raw data of RNAseq analyses
Metabolic and clinical outcomes in nondiabetic individuals with the metabolic syndrome assigned to chlorthalidone, amlodipine, or lisinopril as initial treatment for hypertension: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
Doctor-Led Plans : We recommend GLP-1 drugs when they align with your unique metabolism
USCS data brief, No
US$ 25.30
US$ 28.22
.png)
US$ 28.05
US$ 21.77
